Atlas FDA

LT-CAGE TAPERED FUSION DEVICE

FDA premarket approval P970015/S020 · decided 2002-08-12

Approval details

PMA number
P970015
Supplement
S020
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
LT-CAGE TAPERED FUSION DEVICE
Generic name
Intervertebral fusion device with bone graft, lumbar
Applicant
Sofamor Danek
Date received
2002-04-04
Decision date
2002-08-12
Days to decision
130 days
Decision code
APPR
Product code
MAX
Advisory committee
Orthopedic
Expedited review
No
Location
Memphis, TN
Statement
APPROVAL FOR A REVISED LAPAROSCOPIC SURGICAL TECHNIQUE FOR IMPLANTATION OF THE LT-CAGE. THE DEVICE REMAINS MARKETED UNDER THE TRADE NAME LT-CAGE TAPERED FUSION DEVICE AND IS INDICATED FOR SPINAL FUSION PROCEDURES IN SKELETALLY MATURE PATIENTS WITH DEGENERATIVE DISC DISEASE (DDD) AT ONE LEVEL FORM L2-S1. DDD IS DEFINED AS DISCOGENIC BACK PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY PATIENT HISTORY AND RADIOGRAPHIC STUDIES. THESE DDD PATIENTS MAY ALSO HAVE UP TO GRADE I SPONDYLOLISTHESIS OR RET

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MODIFICATION TO ZPLATE-ATL ANTERIOR FIXATION SYSTEM (K991460)Sofamor Danek1999-05-19